Barragán JRL, Huerta RJF, Cázares GLR, Montoya GE

Idioma: Español
Referencias bibliográficas: 19
Paginas: 256-260
Archivo PDF: 214.92 Kb.

RESUMEN

Se presenta el caso de una niña de 11 años con VIH/SIDA y una masa abdominal referida como probable linfoma. Su historia destaca el mal apego al tratamiento antirretroviral y durante sus estudios de laboratorio, imagen y biopsia descartan el diagnóstico y prueban que se trata de tuberculosis/VIH/SIDA, con localización intestinal.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Bloom BR, Murray CJ. Tuberculosis: commentary on a reemergent killer. Science 1992; 257: 1055-64.

2. Corbett EZ, Watt CJ, Walker N et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009-21.

3. Thomas P, Bomschlegel K, Pal-Sinh T, Abrams EJ, Cervia J, Fikrig S et al. Tuberculosis in human immunodeficiency virus-infected and human immunodeficiency virus-Center for Disease Control and Prevention: Tuberculosis morbidity-United States, 1997. MMWR 1998; 47: 253-7.

4. Mercado MF, Gloyd S, Duming J. Riesgo de infección por tuberculosis en las jurisdicciones sanitarias de Jalisco, México. Salud Pública Mex 1992; 34: 499-505.

5. Metha JB, Dutt A, Harvill L et al. Epidemiology of extrapulmonary tuberculosis: a comparative analysis with pre-AIDS era. Chest 1991; 99: 1134-8.

6. Jakubowski A, Elwood RK, Enarson DA. Clinical features of abdominal tuberculosis. J Infect Dis 1988; 158: 687-9

7. Sheerman S, Rohwedder JJ, Ravikrishnan KP et al. Tuberculous enteritis and peritonitis: Report of 36 General Hospital cases. Arch Intern Med 1980; 140: 506-8.

8. Klimach OE, Ormerod LP. Gastrointestinal tuberculosis: A retrospective review of 109 cases in a district General Hospital. Q J Med 1985; 56: 569-78.

9. Miedema F, Petit AJ, Terpstra FG, Schattenkerk JK, de Wolf F, Al BJ et al. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+T helper cell depletion occurs. Journal of Clinical Investigation 1988; 82: 1908-14.

10. Schluger NW, Rom WN. The host immune response to tuberculosis. Am J Respir Crit Care Med 1998; 157: 679-91.

11. Schluger NW, Pérez D, Lui YM. Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy. Chest 2002; 122: 597-602.

12. Daley CL, Small PM, Schecter GF et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992; 326: 231-5.

13. Raviglione MC, Harries AD, Msiska R, Wilkinson D, Nunn P. Tuberculosis and HIV: current status in Africa AIDS 1997; 11(Suppl B): S115-S23.

14. Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey-Faussett P. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 2001; 358: 1678-93.

15. Fitzpatrick LK, Okwera A, Mugerwa R, Ridzon R, Ehiner J, Onorato I. An investigation of suspected exogenous reinfection in tuberculosis patients in Kampal, Uganda. Int J Tuberc Lung Dis 2002; 6: 550-2.

16. Goletti D, Weissman D, Jackson RW et al. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J Immunol 1996; 157: 1271-8.

17. Styblo K, Meijer J, Sutherland I. The transmission of tubercle bacilli: its trend in a human population. Bull World Health Organ 1969; 41: 137-78.

18. Sutherland I. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Adv Tuberc Res 1976; 19: 1-63.

19. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general review. Adv Tuberc Res 1969; 17: 28-106.